The Transfusion Evidence Round-Up is a collaboration between the International Society of Blood Transfusion (ISBT) and the Transfusion Evidence Library (TEL). No images? Click here Transfusion Evidence Round-Up Bleeding Disorders: World Haemophilia Day 2023 Welcome to the quarterly Transfusion Evidence Round-Up. This is a collaboration between the International Society of Blood Transfusion (ISBT) and the Transfusion Evidence Library (TEL). We aim to highlight high quality evidence randomised controlled trials and systematic reviews about an internationally relevant subject in the field of Transfusion Medicine. All references are drawn from the Transfusion Evidence Library and, where relevant, Stem Cell Evidence. This Transfusion Evidence Round-Up is sent to ISBT members and TEL subscribers, so if you are a subscriber to both mailing lists and receive it twice please bear with us until we can resolve this. The Transfusion Evidence Library is produced by the Systematic Review Initiative (SRI) and funded by the four UK blood services. It is available free at the point of access providing a comprehensive and up-to-date database of high quality evidence in Transfusion Medicine. The International Society of Blood Transfusion (ISBT) is a scientific society creating a community of transfusion medicine professionals from around the globe. ISBT works towards its vision of "a world of safe and sufficient blood" by undertaking advocacy for patient and donor safety, sharing knowledge to enhance transfusion practice and providing opportunities for education. Top Article Platelet-to-red blood cell ratio and mortality in bleeding trauma patients: A systematic review and meta-analysis. Selected Articles IVMP+IVIG raises platelet counts faster than IVIG alone: results of a randomized, blinded trial in childhood ITP. Effects of replacement therapies with clotting factors in patients with hemophilia: A systematic review and meta-analysis. Comparative efficacy and safety of thrombopoietin receptor agonists in adults with thrombocytopenia: A systematic review and network meta-analysis of randomized controlled trial. Risk factors for bleeding in people living with Hemophilia A and B treated with regular prophylaxis: a systematic review of the literature. The impact of recombinant versus plasma-derived factor VIII concentrates on inhibitor development in previously untreated patients with hemophilia A: A 2021 update of a systematic review and meta-analysis. Pre-procedural use of thrombopoietin-receptor agonists in cirrhosis and severe thrombocytopenia: A systematic review and meta-analysis. Risk of thrombosis with thrombopoietin receptor agonists for ITP patients: a systematic review and meta-analysis. Comparative efficacy of 19 drug therapies for patients with idiopathic thrombocytopenic purpura: a multiple-treatments network meta-analysis. Incidence and mortality rates of intracranial hemorrhage in hemophilia: a systematic review and meta-analysis. Join the Live Journal Club to discuss these top 10 papers on Thursday, 9th March at 09:00 AM (CET). Register here: https://www.isbtweb.org/events/sri-isbt-live-journal-club-transfusion-evidence-round-up-world-haemophilia-day-2023.html The webinar is free and open to all. Editorial Board, Transfusion Evidence Round-Up, March 2023
Jessica Guglielmino - Australia Professor Gesine Weckmann - Germany |